1. Merck Sharp & Dohme LLC Rahway NJ USA.PREVYMIS™ (letermovir) prescribing information. Published2022. Updated July 2022. Accessed August 2022.https://www.merck.com/product/usa/pi_circulars/p/prevymis/prevymis_pi.pdf
2. European Medicines Agency (EMA).Prevymis summary of product characteristics. Published2018. Accessed August 2022.https://www.ema.europa.eu/en/documents/product-information/prevymis-epar-product-information_en.pdf
3. Small Molecules—Prospective Novel HCMV Inhibitors
4. Absorption, Metabolism, Distribution, and Excretion of Letermovir